G P Linette
Overview
Explore the profile of G P Linette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DAngelo S, Bhatia S, Brohl A, Hamid O, Mehnert J, Terheyden P, et al.
ESMO Open
. 2021 Oct;
6(6):100290.
PMID: 34715570
Background: Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer that has a poor prognosis in patients with advanced disease. Avelumab [anti-programmed death-ligand 1 (PD-L1)] became the first approved...
2.
Staser K, Chen D, Solus J, Rosman I, Schaffer A, Cornelius L, et al.
Br J Dermatol
. 2016 Feb;
175(2):391-3.
PMID: 26877232
Tumoral melanosis describes a pigmented lesion clinically similar to melanoma but on histology reveals dense aggregates of melanin-laden, benign macrophages without malignant cells. In the few reported cases so far,...
3.
Alhamad T, Venkatachalam K, Linette G, Brennan D
Am J Transplant
. 2016 Jan;
16(4):1332-3.
PMID: 26752406
No abstract available.
4.
Yang S, Linette G, Longerich S, Roberts B, Haluska F
Cell Immunol
. 2000 Sep;
204(1):29-37.
PMID: 11006015
HLA-A2.1/K(b) transgenic mice (A2.1/K(b) mice) were used to investigate the processing of human gp100 melanoma antigen by murine antigen presenting cells (APC). Bone marrow-derived dendritic cells (DC) from A2.1/K(b) mice...
5.
Jonasch E, Kumar U, Linette G, Hodi F, Soiffer R, RYAN B, et al.
Cancer J
. 2000 Jul;
6(3):139-45.
PMID: 10882328
We performed an analysis of toxicity and survival in stage III melanoma patients receiving adjuvant interferon alfa-2b (IFN). This was a retrospective single-arm analysis of 40 patients with stage III...
6.
Linette G, Shankara S, Longerich S, Yang S, DOLL R, Nicolette C, et al.
J Immunol
. 2000 Mar;
164(6):3402-12.
PMID: 10706736
Replication-deficient recombinant adenovirus (Ad) encoding human gp100 or MART-1 melanoma Ag was used to transduce human dendritic cells (DC) ex vivo as a model system for cancer vaccine therapy. A...
7.
Linette G, Li Y, Roth K, Korsmeyer S
Proc Natl Acad Sci U S A
. 1996 Sep;
93(18):9545-52.
PMID: 8790367
BCL-2-deficient T cells demonstrate accelerated cell cycle progression and increased apoptosis following activation. Increasing the levels of BCL-2 retarded the G0-->S transition, sustained the levels of cyclin-dependent kinase inhibitor p27Kip1,...
8.
Chao D, Linette G, Boise L, White L, Thompson C, Korsmeyer S
J Exp Med
. 1995 Sep;
182(3):821-8.
PMID: 7650488
The effect of Bcl-xL upon the developmental death of T cells was assessed by generating transgenic mice that expressed Bcl-xL within all thymocyte subsets. Bcl-xL protected thymocytes from a variety...
9.
Linette G, Hess J, Sentman C, Korsmeyer S
Blood
. 1995 Aug;
86(4):1255-60.
PMID: 7632929
t(14;18) is the most common translocation in human lymphoid malignancy and results in bcl-2 overexpression. Bcl-2 blocks apoptosis and constitutes the initial member of a new category of oncogenes, ie,...
10.
Lee S, Wesselschmidt R, Linette G, Kanagawa O, Russell J, Milbrandt J
Science
. 1995 Jul;
269(5223):532-5.
PMID: 7624775
T cell hybridomas require the immediate-early gene NGFI-B (nur77) for T cell receptor (TCR)-mediated apoptosis, a model for negative selection of self-reactive T cells. TCR-mediated death was examined in mice...